Gender-Affirming Medical Transition for Transfeminine Individuals
Yes, individuals assigned male at birth can achieve a female-affirmed phenotype through a combination of gender-affirming hormone therapy (GAHT) and surgical procedures, resulting in typically feminine physical characteristics, functional female genitalia, and improved quality of life 1, 2.
Hormone Therapy Approach
The medical transition begins with feminizing GAHT, which produces measurable physical feminization 1, 3:
The standard regimen combines estrogen with antiandrogen therapy to suppress testosterone to female range (<50 ng/dL) 1. The most commonly used antiandrogens include:
- Spironolactone
- Cyproterone acetate
- GnRH agonists
This dual approach allows lower estrogen doses while achieving optimal feminization 1.
Physical Changes from Hormone Therapy
GAHT produces substantial feminizing effects 1:
Body composition changes:
- Lean body mass decreases by 3-5%
- Thigh muscle volume decreases by 5%
- Quadriceps cross-sectional area decreases by 4%
- Body fat increases and redistributes in feminine pattern
Breast development:
- 16% achieve B cup size
- 9% achieve A cup size
- Development continues for the first 3 years of therapy
- May extend beyond the timeframe noted in Endocrine Society guidelines 1
Other feminizing effects:
- Decreased facial and body hair
- Feminized body shape and fat distribution
- Decreased hemoglobin levels 1
Surgical Procedures
Gender reassignment surgery provides anatomically functional and aesthetically appropriate female genitalia 2, 4, 5. The core surgical procedures include 2:
Genital procedures:
- Orchiectomy (removal of testes)
- Penectomy (removal of penis)
- Vaginoplasty (creation of neovagina)
- Clitorolabioplasty (creation of clitoris and labia)
Surgical outcomes are favorable 4, 5:
- Mean neovaginal depth: 11 cm (range 10-14 cm)
- 97% report good to excellent neoclitoral sensation
- 33% report regular intercourse
- All patients in one series reported satisfactory vaginal functionality 5
Non-genital procedures complete the physical transition 2:
- Breast augmentation (if hormone therapy alone insufficient)
- Facial feminization surgery
- Voice surgery
- Other feminization procedures
Surgical Considerations
The procedures utilize penile skin with incorporated urethra to create the neovagina, with the glans preserved and resized to form a sensate neoclitoris 5. Secondary procedures are frequently required - 13 of 60 patients in one series needed aesthetic revision surgery 4. Minor complications occur but major complications are rare with experienced surgeons 4, 5.
Safety Profile
Feminizing GAHT carries a low risk profile for most patients 3. The therapy is highly effective for achieving medically necessary changes in secondary sex characteristics. However, knowledge gaps exist regarding:
- Hormone management around the time of surgery
- Long-term risks in aging transgender populations 3
Important Caveats
- Cyproterone acetate as antiandrogen has debated health risks; randomized protocols with alternative antiandrogens are needed 6
- Natural progesterone is not currently recommended due to limited knowledge on risk-benefit balance 6
- Despite careful surgical technique, secondary procedures are frequently required to optimize function and appearance 4
- Trans women retain greater muscle cross-sectional area than cisgender women even after 12-36 months of GAHT 1
The combination of hormone therapy and surgery enables transfeminine individuals to achieve a female phenotype with functional anatomy, appropriate secondary sex characteristics, and documented improvements in psychological and social well-being 3.